发明授权
US6133260A Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic
acid and naphthyridon carboxylic acid derivatives for the treatment of
Helicobacter pylori infections and associated gastroduodenal diseases
有权
使用7-（2-氧杂-5,8-二氮杂双环[4.3.0]壬-8-基） - 喹诺酮羧酸和萘啶酮羧酸衍生物用于治疗幽门螺杆菌感染和相关的胃十二指肠疾病
- 专利标题： Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases
- 专利标题（中）： 使用7-（2-氧杂-5,8-二氮杂双环[4.3.0]壬-8-基） - 喹诺酮羧酸和萘啶酮羧酸衍生物用于治疗幽门螺杆菌感染和相关的胃十二指肠疾病
-
申请号： US319888申请日： 1999-06-14
-
公开(公告)号： US6133260A公开(公告)日： 2000-10-17
- 发明人: Michael Matzke , Uwe Petersen , Thomas Jaetsch , Stephan Bartel , Thomas Schenke , Thomas Himmler , Bernd Baasner , Hans-Otto Werling , Klaus Schaller , Harald Labischinski
- 申请人： Michael Matzke , Uwe Petersen , Thomas Jaetsch , Stephan Bartel , Thomas Schenke , Thomas Himmler , Bernd Baasner , Hans-Otto Werling , Klaus Schaller , Harald Labischinski
- 申请人地址： DEX Leverkusen
- 专利权人： Bayer Aktiengesellschaft
- 当前专利权人： Bayer Aktiengesellschaft
- 当前专利权人地址： DEX Leverkusen
- 优先权： DEX19652239 19961216
- 主分类号： A61K31/47
- IPC分类号： A61K31/47 ; A61K31/4709 ; A61K31/5383 ; A61K31/5395 ; A61P1/04 ; A61P31/04 ; C07D498/04 ; C07D519/00 ; C07D265/28 ; A61K31/5365
摘要：
The invention relates to the use of quinolone- and naphthyridonecarboxylic acid derivatives which are substituted in the 7-position by a 2-oxa-5,8-diazabicyclo[4.3.0]-non-8-yl) radical, and their pharmaceutically utilizable hydrates and/or salts for the therapy of Helicobacter pylori infections and the gastroduodenal disorders associated therewith.
公开/授权文献
信息查询
